NCT07534813 2026-04-16
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Metastatic and Recurrent Advanced Solid Tumors
Grit Biotechnology
Phase NA Not yet recruiting
Grit Biotechnology
The First Affiliated Hospital of Xiamen University
Hangzhou Converd Co., Ltd.
Shanghai Salvectors Biotechnology LTD.